Validation and Psychometric Properties of the Asthma Control Questionnaire Among Children

Overview

Journal J Allergy Clin Immunol

Specialty Allergy & Immunology

Date 2013 Aug 13

PMID 23932458

Citations 31

Authors

Jessica M Nguyen

Janet T Holbrook

Christine Y Wei

Lynn B Gerald

W Gerald Teague

Robert A Wise

Affiliations

Soon will be listed here.

Abstract

Background: The Asthma Control Questionnaire (ACQ) is a patient-centered tool for evaluating asthma control. It has been validated in adults, but not well-validated among children.

Objective: We evaluated the reliability, validity, and responsiveness to change of the ACQ for assessing asthma control in children ages 6 to 17 years. A threshold value for poor disease control and a minimally important difference were also determined.

Methods: Data from 305 asthmatic children enrolled in a clinical trial were examined. The ACQ was administered at 8 visits. We analyzed results for the combined age group and for the 6- to 11-year-old and 12- to 17-year-old age groups separately.

Results: Overall, the Cronbach α value (internal consistency) for the ACQ was 0.74 at baseline, and the intraclass correlation coefficient (test-retest reliability) for repeated questionnaires among stable patients was 0.53. The Pearson correlations between the ACQ and other asthma questionnaires were moderate to strong (-0.64 to -0.73). Mean ACQ scores were higher (worse) in patients whose peak flow decreased, who used more rescue medications, or who sought medical care for asthma than in patients who were stable (P < .0001 for all measures). Changes in ACQ scores were significantly different among patients with deteriorating, improving, or stable asthma symptoms (P ≤ .01). The optimal threshold indicating poor asthma control was 1.25 or greater. The minimally important difference was established to be 0.40. Results for the separate age groups were similar.

Conclusion: The ACQ is a moderately reliable, valid, and responsive tool with adequate psychometric properties for assessing recent asthma control among children.

Citing Articles

Diagnostic accuracy of peripheral lung function measurements in paediatric asthma control assessment: a pilot study.

Wawszczak M, Kulus M, Peradzynska J Postepy Dermatol Alergol. 2024; 40(6):772-778.

PMID: 38282871 PMC: 10809824. DOI: 10.5114/ada.2023.133831.

Can the Chinese study on the normal range of FeNO in children evaluate standardized asthma treatment efficacy in 6- to 12-year-old children?.

Yang Q, Cai C, Xu Q, Zheng Y, Li A, Liu Y Front Pediatr. 2023; 11:1189496.

PMID: 37794961 PMC: 10546037. DOI: 10.3389/fped.2023.1189496.

Defining and Promoting Pediatric Pulmonary Health: Leveraging Patient Reported Outcomes.

Rosas-Salazar C, Bacharier L, Buckley L, Amaral S, Sirota S, Moore P Pediatrics. 2023; 152(Suppl 2).

PMID: 37656024 PMC: 10484308. DOI: 10.1542/peds.2023-062292F.

A systematic review of questionnaires measuring asthma control in children in a primary care population.

Bousema S, Bohnen A, Bindels P, Elshout G NPJ Prim Care Respir Med. 2023; 33(1):25.

PMID: 37433825 PMC: 10336001. DOI: 10.1038/s41533-023-00344-9.

Eosinophil granule proteins as a biomarker in managing asthma and allergies.

Kim C, Callaway Z, Pawankar R Asia Pac Allergy. 2023; 13(2):66-71.

PMID: 37388815 PMC: 10287111. DOI: 10.5415/apallergy.0000000000000104.

References

Revicki D, Hays R, Cella D, Sloan J . Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008; 61(2):102-9. DOI: 10.1016/j.jclinepi.2007.03.012. View

Juniper E, Bousquet J, Abetz L, Bateman E . Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med. 2005; 100(4):616-21. DOI: 10.1016/j.rmed.2005.08.012. View

Wyrwich K, Tierney W, Wolinsky F . Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol. 1999; 52(9):861-73. DOI: 10.1016/s0895-4356(99)00071-2. View

Cloutier M, Schatz M, Castro M, Clark N, Kelly H, Mangione-Smith R . Asthma outcomes: composite scores of asthma control. J Allergy Clin Immunol. 2012; 129(3 Suppl):S24-33. PMC: 4269334. DOI: 10.1016/j.jaci.2011.12.980. View

Juniper E, Svensson K, Mork A, Stahl E . Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med. 2005; 99(5):553-8. DOI: 10.1016/j.rmed.2004.10.008. View

Sastre J, Olaguibel J, Vega J, Del Pozo V, Picado C, Lopez Vina A . Cut-off points for defining asthma control in three versions of the Asthma Control Questionnaire. J Asthma. 2010; 47(8):865-70. DOI: 10.3109/02770903.2010.491149. View

Schatz M, Sorkness C, Li J, Marcus P, Murray J, Nathan R . Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006; 117(3):549-56. DOI: 10.1016/j.jaci.2006.01.011. View

Revicki D, Leidy N, Sorensen S, Togias A . Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest. 1998; 114(4):998-1007. DOI: 10.1378/chest.114.4.998. View

Guyatt G, Juniper E, Griffith L, Feeny D, Ferrie P . Children and adult perceptions of childhood asthma. Pediatrics. 1997; 99(2):165-8. DOI: 10.1542/peds.99.2.165. View

10.

Juniper E, Guyatt G, Feeny D, Ferrie P, Griffith L, Townsend M . Measuring quality of life in children with asthma. Qual Life Res. 1996; 5(1):35-46. DOI: 10.1007/BF00435967. View

11.

Leidy N, Wyrwich K . Bridging the gap: using triangulation methodology to estimate minimal clinically important differences (MCIDs). COPD. 2006; 2(1):157-65. DOI: 10.1081/copd-200050508. View

12.

Guyatt G, Osoba D, Wu A, Wyrwich K, Norman G . Methods to explain the clinical significance of health status measures. Mayo Clin Proc. 2002; 77(4):371-83. DOI: 10.4065/77.4.371. View

13.

Juniper E, OByrne P, Guyatt G, Ferrie P, King D . Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999; 14(4):902-7. DOI: 10.1034/j.1399-3003.1999.14d29.x. View

14.

Holbrook J, Wise R, Gold B, Blake K, Brown E, Castro M . Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA. 2012; 307(4):373-81. PMC: 4153372. DOI: 10.1001/jama.2011.2035. View

15.

Jaeschke R, Singer J, Guyatt G . Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989; 10(4):407-15. DOI: 10.1016/0197-2456(89)90005-6. View

16.

Hays R, Farivar S, Liu H . Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. COPD. 2006; 2(1):63-7. DOI: 10.1081/copd-200050663. View

17.

Norman G, Sloan J, Wyrwich K . Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003; 41(5):582-92. DOI: 10.1097/01.MLR.0000062554.74615.4C. View

18.

Juniper E, Gruffydd-Jones K, Ward S, Svensson K . Asthma Control Questionnaire in children: validation, measurement properties, interpretation. Eur Respir J. 2010; 36(6):1410-6. DOI: 10.1183/09031936.00117509. View

19.

Yost K, Eton D . Combining distribution- and anchor-based approaches to determine minimally important differences: the FACIT experience. Eval Health Prof. 2005; 28(2):172-91. DOI: 10.1177/0163278705275340. View

20.

Liu A, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S . Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol. 2007; 119(4):817-25. DOI: 10.1016/j.jaci.2006.12.662. View